Analyst Research

Report Title Price
Provider: Reuters Investment Profile
Provider: Wright Reports
Provider: Thomson Reuters StreetEvents
Provider: Thomson Reuters StreetEvents

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Getinge AB Comments on FY 2013 Financial Guidance

Wednesday, 17 Apr 2013 06:00am EDT 

Getinge AB announced that its fiscal year 2013 organic volume growth is expected to remain in line with that of fiscal year 2012 or possibly somewhat better. Fiscal year 2013 profit growth, excluding restructuring costs, is expected to be favorable, even in consideration of the introduction of the Medical Device Tax in the United States at year-end 2012 and negative transaction effects, which, when combined, are expected to total SEK 230 million. 

Company Quote

7.0 +3.16%
6:23am EST